Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical Trials

MeSH terms

• Access to Information*
• Cause of Death
• Disclosure
• Factor Xa Inhibitors / therapeutic use
• Fraud
• Humans
• Multicenter Studies as Topic / standards
• Pyrazoles / therapeutic use
• Pyridones / therapeutic use
• Randomized Controlled Trials as Topic / standards*
• Research Report / standards*
• Rivaroxaban / therapeutic use
• Scientific Misconduct*
• United States
• United States Food and Drug Administration*